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Background: Chronic urticaria (CU) is characterized by itchy recurrent wheals, angioedema, or
both for 6 weeks or longer. CU can greatly impact patients' physical and emotional quality of life.
Patients with chronic conditions are increasingly seeking information from information and com-
munications technologies (ICTs) to manage their health. The objective of this study was to assess
the frequency of usage and preference of ICTs from the perspective of patients with CU.
Methods: In this cross-sectional study, 1800 patients were recruited from primary healthcare
centers, university hospitals or specialized clinics that form part of the UCARE (Urticaria Centers of
Reference and Excellence) network throughout 16 countries. Patients were >12 years old and had
physician-diagnosed chronic spontaneous urticaria (CSU) or chronic inducible urticaria (CIndU).
Patients completed a 23-item questionnaire containing questions about ICT usage, including the
type, frequency, preference, and quality, answers to which were recorded in a standardized
database at each center. For analysis, ICTs were categorized into 3 groups as follows: one-to-one:
SMS, WhatsApp, Skype, and email; one-to-many: YouTube, web browsers, and blogs or forums;
many-to-many: Instagram, Twitter, Facebook, and LinkedIn.
Results: Overall, 99.6% of CU patients had access to ICT platforms and 96.7% had internet access.
Daily, 85.4% patients used one-to-one ICT platforms most often, followed by one-to-many ICTs
(75.5%) and many-to-many ICTs (59.2%). The daily ICT usage was highest for web browsers
(72.7%) and WhatsApp (70.0%). The general usage of ICT platforms increased in patients with
higher levels of education. One-to-many was the preferred ICT category for obtaining generalmatological Allergology, Allergie-Centrum-Charité, Department of
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http://doi.org/10.1016/j.waojou.2020.100475health information (78.3%) and for CU-related information (75.4%). A web browser (77.6%) was by
far the most commonly used ICT to obtain general health information, followed by YouTube
(25.8%) and Facebook (16.3%). Similarly, for CU-specific information, 3 out of 4 patients (74.6%)
used a web browser, 20.9% used YouTube, and 13.6% used Facebook. One in 5 (21.6%) patients
did not use any form of ICT for obtaining information on CU. The quality of the information ob-
tained from one-to-many ICTs was rated much more often as very interesting and of good quality
for general health information (53.5%) and CU-related information (51.5%) as compared to the
other categories.
Conclusions: Usage of ICTs for health and CU-specific information is extremely high in all
countries analyzed, with web browsers being the preferred ICT platform.
Keywords: (3–5) ICT, Information and communications technology, Urticaria, Self-managementINTRODUCTION associated with long-term conditions.10 With anChronic urticaria (CU) is characterized by the
recurrence of itchy wheals, angioedema, or both
for more than 6 weeks and is divided into 2 types:
chronic spontaneous urticaria (CSU), which has no
distinct or definite external trigger,1 and chronic
inducible urticaria (CIndU), of which there are
several subtypes and distinct and definite
external triggers, such as sunlight in solar
urticaria.2 It has been estimated that at any given
time, CSU affects 1% of the global population,
which accounts for approximately two-thirds of all
CU cases.3,4
The intensity of pruritus, recurrence of wheals
and swellings, and unpredictable nature of CU can
all greatly impact patients' quality of life, affecting
both physical and emotional health.5–8 The current
first- and second-line therapies for CU, second-
generation H1-antihistamines at licensed doses
and up dosed (up to 4x) second-generation H1-
antihistamines,2 are insufficient to control the
disease in around half of CSU patients.4 This is
one of the reasons why adherence to medical
treatments is low in patients with CU, with one
study reporting non-compliance with recom-
mended treatment regimens in the majority (72%)
of patients.9
Patients living with chronic conditions are
increasingly turning to self-management educa-
tion (SME) as a means of taking control of their
health. Indeed, SME is recommended because it
can help improve treatment outcomes and quality
of life, and it may reduce depression and anxietyincreasing array of information and
communications technologies (ICTs) available to
facilitate SME, many patients use the internet to
obtain information about their disease.11 ICTs in
healthcare can be defined as digital technologies
that support the exchange, knowledge transfer,
and electronic storage and processing of
information to promote health, manage chronic
illness, and treat disease.12,13 They include web
browsers, emails, forums or blogs, and social
media platforms, as well as various mobile
applications (apps).
ICTs are being explored for medical purposes to
improve clinical outcomes and enhance commu-
nications between healthcare providers (HCPs)
and patients. During the past 25 years, especially
the past 5 years,14 ICTs have become powerful
informational tools to provide health-related
knowledge to HCPs and patients alike.14
A previous study found e-mail and SMS (short
messaging service) to be the most popular forms
of electronic communication for receiving and
seeking information among patients with asthma.
WhatsApp was preferred among patients in the
age category 12–40 years.15
Patients with CU have a high need for knowl-
edge about their disease, to discover more about
its causes, course, possible trigger factors, avail-
able treatment options, and prognosis. This high
need is mirrored by the fact that CU patient-
physician consultations are particularly long and
frequent.16 It is thought that in addition to
Volume 13, No. 11, November 2020 3consultations, ICTs are becoming increasingly
important to patients with CU, who use ICTs to
interact with each other about their condition, to
share coping experiences, to offer social support,
and to support communication with their
physician. The current study aims to investigate
this further.
As of yet, it is not known which general or spe-
cific ICTs patients use to obtain information on
health-related topics and specifically on CU, or
how patients perceive the currently available in-
formation via ICTs. Gaining knowledge on this is
important to better inform CU patients about their
disease, to match the right informational content
to the right ICTs, and to provide CU-specific ICT
platforms if seen as necessary by patients. To this
end, an international study was set up in the
UCARE (Urticaria Centers of Reference and Excel-
lence) network17 to assess the frequency and
preference of ICTs used by CU patients for
general health-related and CU-related informa-
tion, and to assess the quality of information
available via ICTs from the patients' perspective.METHODS
Study design and setting
In this anonymous, cross-sectional study, 1800
patients were recruited from primary healthcare
centers, university hospitals or specialized clinics
(public or private), that are part of the UCARE
network. The following countries were involved:
Germany, Greece, Spain, Poland, Turkey,
Switzerland, the Netherlands, Denmark, India,
Russia, Brazil, the United Arab Emirates (UAE),
Peru, Iran, Argentina, and China.
Patient population
Patients were included on a first-come basis, if
they were over 12 years old and had physician-
diagnosed CSU or CIndU. Patients were
excluded if they had a diagnosis of any other
dermatological disorder (eg, contact dermatitis),
had an intellectual disability, or refused to partici-
pate in the study.
Data collection and measurements
During or after a medical consultation, or during
their stay at a health center, each patientcompleted the study-related questionnaire (see
Supplement 1) in the presence of trained medical
staff, who answered any queries if they arose.
For this purpose, a 23-item questionnaire was
developed and reviewed by an expert panel of
physicians who evaluated potential items to be
included. The final survey contained a range of
questions about the use of ICTs; reported herein
are results on the type, frequency, preference, and
patient-rated quality of ICTs, for obtaining infor-
mation on health topics in general, and for getting
information specifically about CU.
The questionnaire assessed whether patients
owned a cell phone, a smartphone, and had
internet access. It evaluated the usage rate (daily,
at least once a week, at least once a month, less
than once a month, and never) of several ICTs,
online communication tools, and social media
platforms (WhatsApp, email, SMS, Skype, web
browser, YouTube, blog or forum, Facebook,
Instagram, Twitter, and LinkedIn). Additionally, the
questionnaire quantified patients’ use of ICTs, and
rated the quality of general health-related and CU-
related information patients obtained through
various ICT platforms using the following scale: not
interesting, a little interesting, moderately inter-
esting, very interesting, and extremely interesting.
Furthermore, the questionnaire evaluated pa-
tient demographics, including the type of CU, age,
sex, duration of CU, area of residence, education
level, and employment status.Standardization of data
To help standardize the results, researchers
trained interviewers and data collectors on the
content of the survey and on how to answer pa-
tients' questions before completion. Surveys
collected at each center were recorded in a stan-
dardized database, which were then transferred to
the leading center and consolidated in a single
central database for processing and statistical
analysis. Data security and protection was pre-
served at all points during this process.Ethical considerations
Before participating in the survey, patients were
informed in detail about the purpose of the study
and all provided verbal informed consent.
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Comité de ética e Investigación en Seres Humanos
(HCK-CEISH-19-0059), Guayaquil, Ecuador, and by
the ethics committees of the participating UCAREs,
as required. With the information recollected in the
survey, personal identification was not possible; asType of chronic urticaria (%)
- CSU
- CIndU
- CSU þ CIndU
- No information
Mean ageSD (median) in years 4
Sex distribution (female:male) (%)
Mean duration of urticariaSD (median) in years


















Table 1. Population characteristics and demographics. CIndU, chronic in
communications technology; n, number of patients; SD, standard deviation.such anonymity and personal data protection were
preserved.Statistical analysis
A chi-squared test was employed to assess the
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Volume 13, No. 11, November 2020 5characteristics (independent variables) and
internet access or owning a cell phone or smart-
phone, and the frequency of use of each ICT type.
For data analysis, we categorized the ICTs post-
hoc into one of the following three categories:
 One-to-one (dialogic): SMS, WhatsApp, Skype,
and email
 One-to-many (informative): YouTube, web
browsers, and blogs or forums
 Many-to-many (social): Instagram, Twitter, Face-
book, and LinkedIn
All data were analyzed using SPSS version 22.0
software (SPSS Inc., Chicago, IL, USA). A p-value of
less than 0.05 was considered significant for all
tests. In case of missing data, these data were not
included in the calculation of proportions but the
number of missing datasets is provided.RESULTS
Population characteristics
Table 1 shows the overall population
characteristics and demographics for this study.
Patients covered a wide range of age groups and
included those with CSU (1134/1,800, 63.0%),
CIndU (328/1,800, 18.2%), and CSU þ CIndU
(334/1,800, 18.6%). For questionnaire
contributions by country, see Supplement 2. Most
patients were educated to secondary/high schoolFig. 1 Patients were asked how often they used each ICT for any purp
browsers, blogs or forums [one-to-many]; Instagram, Twitter, Faceboo
never, less than once a month, at least once a month, at least once a we
purposes of analysis. Missing information is not included in the compu(583/1,800, 32.4%) or undergraduate/college
level (622/1,800, 34.6%), and half (901/1,900,
50.1%) were in employment.
Almost all CU patients have access to ICTs and use
them regularly
ICT platforms were broadly used by all CU pa-
tients: 99.6% of 1800 patients (yes n ¼ 1791; no
n¼ 8; missing n¼ 1) had access to ICTs (as either a
cell phone [of any type and functionality], smart-
phone, or internet access (via any means), 94.9%
(yes n ¼ 1709; no n ¼ 91) had a smartphone, and
96.8% (yes n ¼ 1741; no n ¼ 58; missing n¼ 1) had
internet access.
Daily, 85.4% of patients (yes n ¼ 1286; no
n ¼ 220; missing n ¼ 294) used one-to-one ICT
platforms most often, followed by one-to-many
ICTs (75.5%; yes n ¼ 1172; no n ¼ 381; missing
n ¼ 247), and many-to-many ICTs (59.2%; yes
n ¼ 967; no n ¼ 667; missing n ¼ 166; Fig. 1). The
daily ICT usage was highest for web browsers
(72.7%) and WhatsApp (70.0%), followed by
emails (54.1%), SMS (46.2%), Facebook (44.6%),
YouTube (35.5%), and Instagram (33.7%; Fig. 2).
ICT usage differs depending on country, level of
education and age
There were no major differences concerning
sex; one-to-one ICTs were used by 92.3% (yes
n ¼ 431; no n ¼ 36; missing n ¼ 77) of males and
92.8% (yes n ¼ 964; no n ¼ 75; missing n ¼ 217) ofose (SMS, WhatsApp, Skype, email [one-to-one]; YouTube, web
k, LinkedIn [many-to-many]) by ticking one of the following boxes:
ek, and every day. The results were grouped by ICT category for the
tation of proportions.
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saw no differences with the residential area; one-
to-one ICTs were used by 95.3% (yes n ¼ 381; no
n ¼ 19; missing n ¼ 62) of patients living in rural
areas and 91.7% (yes n ¼ 1014; no n ¼ 92; missing
n ¼ 232) of patients living in urban areas every day
or at least weekly. The use of ICTs did not appear
to change with the duration of disease, but pa-
tients who had experienced CU for 1–2 years used
ICTs slightly more often to obtain general health
and CU-related information than those patients
with a longer disease duration.
Considerable differences exist between coun-
tries; general ICT usage was weak in Iran, China,Pa ent 
numbers 
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Fig. 2 Patients were asked how often they used each ICT for any purpos
forums, Instagram, Twitter, Facebook, and LinkedIn) by ticking one of t
month, at least once a week, every day.The graph shows the percentag
each box. Missing information is not included in the computation of pand Greece, and comparably strong in India,
Turkey, the UAE, Peru, and the Netherlands. ICTs
in the many-to-many category were used particu-
larly infrequently in Iran and often used in India,
Denmark, Turkey, the UAE, and Peru.
The general usage of ICT platforms increased in
patients with higher levels of education, which was
true across all three ICT categories; one-to-one ICT
platforms were used every day or at least once a
week in patients with no schooling (63.6%; yes
n ¼ 7; no n ¼ 4; missing n ¼ 1), middle/primary
school (74.0%; yes n ¼ 94; no n ¼ 33; missing
n ¼ 26), secondary/high school (92.6%; yes
n ¼ 438; no n ¼ 35; missing n ¼ 110),Blog or 
forum
Facebook Instagram Twi er Linked
In
Other
49 776 590 139 67 206
114 173 152 62 89 27
163 949 742 201 156 233
87 61 51 48 62 706
; SMS, short messaging service
e (SMS, WhatsApp, Skype, email, YouTube, web browsers, blogs or
he following boxes: never, less than once a month, at least once a
e of patients and the table shows the number of patients who ticked
roportions.
Volume 13, No. 11, November 2020 7undergraduate/college (96.6%; yes n ¼ 511; no
n ¼ 18; missing n ¼ 93), and postgraduate studies
(94.2%; yes n ¼ 342; no n ¼ 21; missing n ¼ 64).
One-to-one ICTs were used by large proportions
of all age groups, while one-to-many ICTs and,
particularly many-to-many ICTs, were less often
used by patients 40 years and older, with further
decreasing frequency in older age groups.One-to-many ICTs are most commonly used by
CU patients to obtain general health and CU-
related information
One-to-many was the preferred ICT category for
obtaining general health information, used by
78.9% of patients (yes n ¼ 1410; no n ¼ 377;
missing n ¼ 13) and for obtaining CU-related in-
formation (used by 75.9% of patients; yes
n ¼ 1357; no n ¼ 431; missing n ¼ 12). Web
browsers (77.6%; yes n ¼ 1391; no n ¼ 401;
missing n ¼ 8) were by far the most commonly
used ICTs to obtain general health information,
followed by YouTube (25.8%; yes n ¼ 461; no
n ¼ 1329; missing n ¼ 10) and Facebook (16.3%;
yes n ¼ 292; no n ¼ 1499; missing n ¼ 9; Fig. 3);
18.6% of patients (no n ¼ 331; missing n ¼ 17)
did not use an ICT platform for this purpose.
Similarly, when obtaining information specifically
on CU, 3 out of 4 patients (74.6%; yes n ¼ 1336;
no n ¼ 456; missing n ¼ 8) used a web browser,
20.9% (yes n ¼ 374; no n ¼ 1417; missing n ¼ 9)Fig. 3 Patients were asked if they had used any of the following types of
or specifically to obtain information about urticaria; they could mark o
SMS, WhatsApp, Skype, email, YouTube, web browsers, blogs or forum
patients, proportions are provided. Missing information is not includedused YouTube and 13.6% (yes n ¼ 244; no
n ¼ 1547; missing n ¼ 9) used Facebook. One in
5 (21.6%; no n ¼ 385; missing n ¼ 14) patients
did not use any form of ICT for obtaining
information on CU.
There were no major sex differences concerning
the use of ICT platforms to obtain general health or
CU-related information. Patients with a higher level
of education used ICTs more often to obtain in-
formation on general health or CU, thus mirroring
the use of ICTs for any purpose.
Usage of ICTs for general health information
was similar for various age ranges of adult patients,
but ICTs were used less frequently by retired pa-
tients >60 years and younger patients <20 years
(Table 2). One-to-many ICTs and, particularly
many-to-many ICTs, were less often used by pa-
tients 40 years or older.
Patients living in rural areas tended to use ICT
platforms slightly more often than those living in
urban areas. This was particularly so for the many-
to-many ICTs, to obtain general health information
(27.9% vs. 17.8%), and especially for information
on CU (26.2% vs. 13.8%; Table 2).
Patients rate one-to-many ICTs as the most
interesting for obtaining health information
The quality of the information obtained from
one-to-many ICTs was rated much more often asmedia to obtain information on their health and medical problems,
ptions for general health information and CU-specific information:
s, Instagram, Twitter, Facebook, and LinkedIn. Analyses of all
in the computation of proportions.
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(continued)
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Table 2. ICT usage by category for general health information and chronic urticaria-related information. Missing information is not included in
the computation of proportions. ICT, information and communications technology; n, number of patients.
Fig. 4 If patients had answered yes for using any type of media to obtain information about their health and medical problems or urticaria,
the were asked how they rated the quality of information they obtained using one of the following categories: 1) not interesting, not helpful,
very low quality; 2) slightly interesting, somewhat helpful, low quality; 3) moderately interesting and helpful, medium quality; 4) very
interesting and helpful, good quality; 5) extremely interesting and helpful, very good quality. Data shown are for platforms that patients
rated as very or extremely interesting/of good or very good quality A. by ICT category and B. by ICT platform. All patients were analyzed.
Missing information is not included in the computation of proportions.
Volume 13, No. 11, November 2020 9
10 Maurer et al. World Allergy Organization Journal (2020) 13:100475
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interesting/of very good quality for general health
information (53.5%; yes n ¼ 268; no n ¼ 233;
missing n ¼ 1299) and CU-related information
(51.5%; yes n¼ 257; no n¼ 242; missing n¼ 1301)
as compared to the one-to-one and many-to-many
categories (Fig. 4A). Fig. 4B shows the patient-
rated quality of information by specific ICT plat-
form, which indicates that web browsers were
rated most often as very or extremely interesting,
or of good or very good quality. However, full in-
formation on the quality of information was avail-
able for only around 500 patients.
DISCUSSION
Top-line results
This study is the first to demonstrate the ICT
usage habits of patients with CU; results indicate
that almost all (99.6%) patients had access to ICT
platforms.To obtain general health and CU-related
information, the one-to-many category was
preferred, with web browsers being the over-
whelming favorite, used by three out of four pa-
tients. The next most commonly used, YouTube,
was used only by around one in four patients.
The population of this study
In total, 63.0% of patients included in this study
had CSU, reiterating current estimates that CSU
accounts for around two-thirds of all CU cases.4
We predicted that certain independent variables
such as age and employment status had the
potential to influence the use of ICTs; thus, to try
to account for this we recruited a heterogeneous
patient population that covered a range of ages,
and we stratified results by patient characteristics.
Almost all CU patients have access to ICTs
Interestingly, only 0.4% of patients in this study
did not have access to ICTs via cell phone, smart-
phone, or internet access. This is surprising
because we included a wide cross-section of
countries; the results indicate that the inclusion of
lower-income countries did not appear to affect
the accessibility to the internet. A previous report
of ICT use in cancer patients in Ecuador found that
only 43% of participants surveyed had internet
access,18 less than half of what we report here.
However, another report in patients withhypertension, also in Ecuador, showed internet
access to be around 80%,19 indicating
inconsistency across various medical conditions.Patients use ICTs regularly for any purpose
Daily, patients used one-to-one (SMS, What-
sApp, Skype, and email) ICTs most often, followed
by one-to-many (YouTube, web browsers, and
blogs or forums), and many-to-many (Instagram,
Twitter, Facebook, and LinkedIn) ICT platforms.
The highest usage for specific ICT platforms were
web browsers (72.7%) and WhatsApp (70.0%); this
indicates that in addition to the one-to-many ICT
web browsers, patients also display a high de-
mand to communicate and acquire information
through personalized one-to-one means. It should
be noted, however, that some patients may have
answered yes for the use of web browsers, You-
Tube, and blogs/forums ICTs, as YouTube and
blogs/forums require a web browser for access.ICT usage differs depending on country, age and
level of education
We observed considerable differences in ICT
usage between countries; general ICT usage was
weak in Iran, China, and Greece, and comparably
strong in India, Turkey, the UAE, Peru, and the
Netherlands. ICTs in the many-to-many category
were used particularly infrequently in Iran and
often used in India, Denmark, Turkey, the UAE, and
Peru. Low use in Iran and China may be explained
by the fact that many-to-many ICTs are highly
regulated or difficult to access in these countries,
especially social media platforms like Facebook
and Twitter. However, we saw an unexpectedly
high use of ICTs in the UAE, which also has high
levels of censoring. The reasons behind this would
be worth exploring in more detail to assess how
this could affect optimal use; lower ICT usage in
censored countries may have implications on
development strategies for any new ICT.
Data have suggested that the use of ICTs cor-
relates with an individual's level of education;
higher levels of education are associated with
increased ICT use or increased interest in using
ICTs for health purposes.20 As expected, we found
that more educated patients used ICTs frequently
to acquire information on general health or CU.
Nevertheless, ICTs were used by over 63% of
Volume 13, No. 11, November 2020 11patients with no schooling, indicating widespread
use regardless of the level of education.One-to-many ICTs are most commonly used by
CU patients to obtain general health and CU-
related information
One-to-many was the preferred ICT category for
obtaining general health and CU-related informa-
tion. This usage differs slightly from the ICT usage
for any purpose, in that the frequency of What-
sApp use was substantially lower for health pur-
poses. Patients used all the one-to-many platforms
included in this study, plus Facebook, most often
for acquiring health information, with relatively low
usage of the other ICTs; this indicates that the one-
to-many category is a clear favorite for CU patients,
with a broad range of individuals being reached
through these means.
Mirroring the general ICT usage, web browsers
were without doubt the most commonly used ICTs
for health and CU information, used by more than
3 out of 4 patients. The high use of web browsers
also aligns with findings from other medical con-
ditions, such as cancer.18 These results point to a
potential question around patients’ perceptions
of credibility; patients are more likely to trust a
named, accredited medical organization, such as
the National Institute for Health and Care
Excellence when seeking knowledge about their
condition. They would likely have less confidence
in reports, advertisements, and sponsored
content on Instagram or Twitter because
misinformation can quickly disseminate between
individuals sharing posts, and the true source is
often unidentified. It would be interesting to
investigate further which websites patients use
most often to seek CU information as the current
information offers little insight into the most
highly used websites.
Our results indicate that YouTube was the next
most commonly used platform; however, usage
dropped significantly to only 1 out of every 4 pa-
tients. YouTube could represent a feasible means
for educating patients on CU. However, many
videos are misleading, poor-quality, and uploaded
by individuals with unknown credentials, with
some even promoting unproven alternative treat-
ments.21 Concerningly, one study investigating
ICTs use in patients with hypertension found thatthe quality of YouTube videos was a poor
predictor of viewer engagement. Individuals
watched videos containing misleading or false
information significantly more often compared to
videos containing accurate information on
hypertension.21 If HCPs advocate the use of a
particular ICT to patients, they must have a
responsibility to ensure high-quality and accurate
information.22
Notably, the use of ICTs for obtaining health
information was significantly reduced in older,
retired patients. This low usage could be due to
many factors concerning older generations,
including age-related cognitive decline, negative
attitudes towards technologies, perceived lack of
usefulness,23 or simply no inclination to learn
about new technologies; many older patients
prefer to speak to their doctor or friends face-to-
face.
The higher use of ICTs by patients living in rural
areas vs. urban areas indicates that access to
specialists is more limited in rural areas. It indicates
that approaches to improving patient care through
the use of ICTs may be especially helpful in
countries or regions with a high rate of people and
patients living in rural areas. Moreover, patients
who live in rural areas may have different needs
and expectations when it comes to ICTs. This
should be explored further and specific strategies
need to be developed to improve care in this pa-
tient population, based on the results of future
studies.Patients rate one-to-many ICTs as the most
interesting for obtaining health information
More than half of patients questioned about the
quality of information obtained from ICTs rated the
one-to-many category as very to extremely inter-
esting/of good or very good quality for health and
CU-related information as compared to the other
categories. Again, this reflects the higher use of
platforms in the one-to-many category, and it fol-
lows that patients use the platforms in which they
have the most interest. It does not necessarily point
to the quality of information, but rather, what pa-
tients find most compelling to read. As indicated
with YouTube, individuals’ viewings are higher for
counterfeit channels rather than legitimate videos
reporting reliable information.21
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tages, including educating patients and HCPs,
improving quality of care and exchange of infor-
mation, and promoting patient-centered health-
care.13,24 Here, for the first time, we show that
almost all CU patients have access to ICTs and
most use them regularly for health and CU-
related information, unlocking new opportunities
for bidirectional patient-physician
communications.Study limitations
This study is limited by the risk of selection bias
in the recruitment process, with the most serious
patients who regularly visit their HCP participating.
Patients included knew the purpose of this study,
which may have influenced their answers. Also, the
accessibility of ICTs differs between countries,
which would have directly affected the results.
Another limitation is that the sample sizes in some
countries were small. Finally, a proportion of the
survey data was missing because not all patients
completed the questionnaires, leading to potential
differences between responders and non-
responders, for which we may have not fully
accounted.CONCLUSIONS
The results of this study show conclusively that
CU patients use ICTs to acquire information about
their condition and that their preferred platform is
a web browser. These results may help support the
development of a CU-specific ICT, which could
provide patients with optimized, tailored disease
management, and ultimately improve patient out-
comes. Based on our results, we recommend that
future efforts on improving patient education and
information on CU should prioritize the one-to-
many category, with particular focus on websites
and YouTube videos from accredited urticaria ex-
perts and centers such as those in the UCARE
network.
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